4 news items
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
EVOK
17 Apr 24
statement. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investor
Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive Officer
EVOK
21 Mar 24
Litigation Reform Act of 1995. Investor & Media Contact:Daniel Kontoh-Boateng DKB PartnersTel
Evoke Pharma Announces Closing of $7.5 Million Public Offering
EVOK
14 Feb 24
the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investor Contact:Daniel
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
EVOK
9 Feb 24
. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investor Contact
- Prev
- 1
- Next